We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
512 hedge funds and large institutions have $12.3B invested in United Therapeutics in 2022 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 168 increasing their positions, 177 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
218% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 28
30% more capital invested
Capital invested by funds: $9.45B → $12.3B (+$2.88B)
28% more funds holding in top 10
Funds holding in top 10: 18 → 23 (+5)
16% more call options, than puts
Call options by funds: $50.3M | Put options by funds: $43.5M
11% more funds holding
Funds holding: 461 → 512 (+51)
5% less repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 177
1.55% less ownership
Funds ownership: 99.94% → 98.39% (-1.5%)
Holders
512
Holders Change
+51
Holders Change %
+11.06%
% of All Funds
8.23%
Holding in Top 10
23
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+27.78%
% of All Funds
0.37%
New
89
Increased
168
Reduced
177
Closed
28
Calls
$50.3M
Puts
$43.5M
Net Calls
+$6.81M
Net Calls Change
-$46.3M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$306M |
| 2 |
FAM
Fred Alger Management
New York
|
+$46.3M |
| 3 |
BlackRock
New York
|
+$46.2M |
| 4 |
Morgan Stanley
New York
|
+$33.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$31.9M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$223M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$98.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$73.1M |
| 4 |
Renaissance Technologies
New York
|
-$51.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$46.6M |
